- Home
- ALLO vs CTV Comparison
ALLO vs CTV Comparison
Compare ALLO & CTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- CTV
- Stock Information
- Founded
- ALLO 2017
- CTV 2007
- Country
- ALLO United States
- CTV United States
- Employees
- ALLO N/A
- CTV N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- CTV Advertising
- Sector
- ALLO Health Care
- CTV Consumer Discretionary
- Exchange
- ALLO Nasdaq
- CTV Nasdaq
- Market Cap
- ALLO 438.2M
- CTV 450.1M
- IPO Year
- ALLO 2018
- CTV N/A
- Fundamental
- Price
- ALLO $1.82
- CTV $3.08
- Analyst Decision
- ALLO Strong Buy
- CTV Hold
- Analyst Count
- ALLO 10
- CTV 3
- Target Price
- ALLO $10.06
- CTV $2.83
- AVG Volume (30 Days)
- ALLO 3.1M
- CTV 2.1M
- Earning Date
- ALLO 03-13-2025
- CTV 02-25-2025
- Dividend Yield
- ALLO N/A
- CTV N/A
- EPS Growth
- ALLO N/A
- CTV N/A
- EPS
- ALLO N/A
- CTV N/A
- Revenue
- ALLO $43,000.00
- CTV $151,557,000.00
- Revenue This Year
- ALLO N/A
- CTV $9.64
- Revenue Next Year
- ALLO N/A
- CTV $10.07
- P/E Ratio
- ALLO N/A
- CTV N/A
- Revenue Growth
- ALLO 26.47
- CTV 12.30
- 52 Week Low
- ALLO $1.78
- CTV $1.25
- 52 Week High
- ALLO $5.78
- CTV $3.40
- Technical
- Relative Strength Index (RSI)
- ALLO 36.69
- CTV 63.17
- Support Level
- ALLO $2.11
- CTV $3.00
- Resistance Level
- ALLO $2.10
- CTV $3.08
- Average True Range (ATR)
- ALLO 0.17
- CTV 0.03
- MACD
- ALLO -0.02
- CTV -0.02
- Stochastic Oscillator
- ALLO 5.69
- CTV 72.73
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.
About CTV Innovid Corp.
Innovid Corp is a software platform that provides ad serving, measurement and optimization creative services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV and desktop TV environments to advertisers, publishers and media agencies. It is engaged in ad serving, measurement and creative services. It operates in U.S., Canada, EMEA, APAC and LATAM, out of which it derives maximum revenue from U.S.